Literature DB >> 22260482

Delving into somatic variation in sporadic melanoma.

Vijay Walia1, Euphemia W Mu, Jimmy C Lin, Yardena Samuels.   

Abstract

Melanoma, the most aggressive form of skin cancer, has increased in incidence more rapidly than any other cancer. The completion of the human genome project and advancements in genomics technologies has allowed us to investigate genetic alterations of melanoma at a scale and depth that is unprecedented. Here, we survey the history of the different approaches taken to understand the genomics of melanoma - from early candidate genes, to gene families, to genome-wide studies. The new era of whole-exome and whole-genome sequencing has paved the way for an in-depth understanding of melanoma biology, identification of new therapeutic targets, and development of novel personalized therapies for melanoma. Published 2012. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2012        PMID: 22260482      PMCID: PMC3374856          DOI: 10.1111/j.1755-148X.2012.00976.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  138 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

Authors:  Vikas K Goel; Alexander J F Lazar; Carla L Warneke; Mark S Redston; Frank G Haluska
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

3.  Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.

Authors:  Todd D Prickett; Xiaomu Wei; Isabel Cardenas-Navia; Jamie K Teer; Jimmy C Lin; Vijay Walia; Jared Gartner; Jiji Jiang; Praveen F Cherukuri; Alfredo Molinolo; Michael A Davies; Jeffrey E Gershenwald; Katherine Stemke-Hale; Steven A Rosenberg; Elliott H Margulies; Yardena Samuels
Journal:  Nat Genet       Date:  2011-09-25       Impact factor: 38.330

4.  Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

Authors:  Sergey I Nikolaev; Donata Rimoldi; Christian Iseli; Armand Valsesia; Daniel Robyr; Corinne Gehrig; Keith Harshman; Michel Guipponi; Olesya Bukach; Vincent Zoete; Olivier Michielin; Katja Muehlethaler; Daniel Speiser; Jacques S Beckmann; Ioannis Xenarios; Thanos D Halazonetis; C Victor Jongeneel; Brian J Stevenson; Stylianos E Antonarakis
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

Review 5.  Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants.

Authors:  Thomas Hocker; Hensin Tsao
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

6.  Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.

Authors:  Kyu Yeong Choi; Kai Chang; James M Pickel; John D Badger; Katherine W Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

7.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

8.  Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer.

Authors:  Cristina G Viloria; Alvaro J Obaya; Angela Moncada-Pazos; María Llamazares; Aurora Astudillo; Gabriel Capellá; Santiago Cal; Carlos López-Otín
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

9.  A novel transforming gene in a human malignant melanoma cell line.

Authors:  R A Padua; N Barrass; G A Currie
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

10.  A novel AKT3 mutation in melanoma tumours and cell lines.

Authors:  M A Davies; K Stemke-Hale; C Tellez; T L Calderone; W Deng; V G Prieto; A J F Lazar; J E Gershenwald; G B Mills
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more
  16 in total

1.  Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.

Authors:  Chi Luo; Jinghao Sheng; Miaofen G Hu; Frank G Haluska; Rutao Cui; Zhengping Xu; Philip N Tsichlis; Guo-Fu Hu; Philip W Hinds
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

2.  A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.

Authors:  Junfeng Xia; Peilin Jia; Katherine E Hutchinson; Kimberly B Dahlman; Douglas Johnson; Jeffrey Sosman; William Pao; Zhongming Zhao
Journal:  Mol Cancer Ther       Date:  2014-04-22       Impact factor: 6.261

Review 3.  Adoptive immunotherapy for cancer: harnessing the T cell response.

Authors:  Nicholas P Restifo; Mark E Dudley; Steven A Rosenberg
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

4.  ATF2 - at the crossroad of nuclear and cytosolic functions.

Authors:  Eric Lau; Ze'ev A Ronai
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

Review 5.  Exploiting the curative potential of adoptive T-cell therapy for cancer.

Authors:  Christian S Hinrichs; Steven A Rosenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.

Authors:  Yongmei Feng; Eric Lau; Marzia Scortegagna; Chelsea Ruller; Surya K De; Elisa Barile; Stan Krajewski; Pedro Aza-Blanc; Roy Williams; Anthony B Pinkerton; Michael Jackson; Lynda Chin; Maurizio Pellecchia; Marcus Bosenberg; Ze'ev A Ronai
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-02       Impact factor: 4.693

7.  Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

Authors:  Cyrille J Cohen; Jared J Gartner; Miryam Horovitz-Fried; Katerina Shamalov; Kasia Trebska-McGowan; Valery V Bliskovsky; Maria R Parkhurst; Chen Ankri; Todd D Prickett; Jessica S Crystal; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

8.  There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis.

Authors:  Rolf K Swoboda; Meenhard Herlyn
Journal:  Exp Dermatol       Date:  2013-03-12       Impact factor: 3.960

9.  Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation.

Authors:  Abel Gonzalez-Perez; Jordi Deu-Pons; Nuria Lopez-Bigas
Journal:  Genome Med       Date:  2012-11-26       Impact factor: 11.117

10.  ERBB4 mutation analysis: emerging molecular target for melanoma treatment.

Authors:  Christopher Lau; Keith J Killian; Yardena Samuels; Udo Rudloff
Journal:  Methods Mol Biol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.